Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kaleebu

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Tropical Medicine & International Health : TM & IH|July 31, 2018
HIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-lineF Fily, E Ayikobua, D Ssemwanga, et al.
AIDS Research and Human Retroviruses|May 3, 2000
An improved algorithm for determining HIV type 1 subtypes in a primary laboratory in UgandaP Kaleebu, D Yirrell, N French, et al.
International Journal of STD & AIDS|May 19, 2007
Association between active GB virus-C (hepatitis G) infection and HIV-1 disease in UgandaD L Yirrell, E Wright, L A Shafer, et al.
International Journal of STD & AIDS|March 10, 2001
The stability between two HIV-1 RNA measurements one year apart and the relationship with HIV subtype in rural UgandaD Morgan, P Kaleebu, J Whitworth, et al.
AIDS (London, England)|August 1, 1991
Comparative humoral responses to HIV-1 p24gag and gp120env in subjects from East Africa and the UKP Kaleebu, R Cheingsong-Popov, D Callow, et al.
AIDS (London, England)|December 1, 1994
Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and BelarusA Bobkov, R Cheingsong-Popov, M Garaev, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 1, 1991
Toxoplasma serology in Zambian and Ugandan patients infected with the human immunodeficiency virusA Zumla, D Savva, R B Wheeler, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2011
Residual activity of two HIV antiretroviral regimens prescribed without virological monitoringD T Dunn, R L Goodall, P Munderi, et al.
AIDS Research and Human Retroviruses|March 28, 2008
Tat-specific binding IgG and disease progression in HIV type 1-infected UgandansD Senkaali, A Kebba, L A Shafer, et al.
The Journal of Infectious Diseases|February 1, 1992
Geographic diversity of human immunodeficiency virus type 1: serologic reactivity to env epitopes and relationship to neutralizationR Cheingsong-Popov, D Callow, S Beddows, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Tropical Medicine & International Health : TM & IH|July 31, 2018
HIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-lineF Fily, E Ayikobua, D Ssemwanga, et al.
AIDS Research and Human Retroviruses|May 3, 2000
An improved algorithm for determining HIV type 1 subtypes in a primary laboratory in UgandaP Kaleebu, D Yirrell, N French, et al.
International Journal of STD & AIDS|May 19, 2007
Association between active GB virus-C (hepatitis G) infection and HIV-1 disease in UgandaD L Yirrell, E Wright, L A Shafer, et al.
International Journal of STD & AIDS|March 10, 2001
The stability between two HIV-1 RNA measurements one year apart and the relationship with HIV subtype in rural UgandaD Morgan, P Kaleebu, J Whitworth, et al.
AIDS (London, England)|August 1, 1991
Comparative humoral responses to HIV-1 p24gag and gp120env in subjects from East Africa and the UKP Kaleebu, R Cheingsong-Popov, D Callow, et al.
AIDS (London, England)|December 1, 1994
Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and BelarusA Bobkov, R Cheingsong-Popov, M Garaev, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 1, 1991
Toxoplasma serology in Zambian and Ugandan patients infected with the human immunodeficiency virusA Zumla, D Savva, R B Wheeler, et al.
Antimicrobial Agents and Chemotherapy|July 20, 2011
Residual activity of two HIV antiretroviral regimens prescribed without virological monitoringD T Dunn, R L Goodall, P Munderi, et al.
AIDS Research and Human Retroviruses|March 28, 2008
Tat-specific binding IgG and disease progression in HIV type 1-infected UgandansD Senkaali, A Kebba, L A Shafer, et al.
The Journal of Infectious Diseases|February 1, 1992
Geographic diversity of human immunodeficiency virus type 1: serologic reactivity to env epitopes and relationship to neutralizationR Cheingsong-Popov, D Callow, S Beddows, et al.
Pageof 5